Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Green Tea and Polyphenon E in COPD
NCT00363805Phase 2Completed
- Start
- May 2004
- Primary completion
- Mar 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of green tea extract in lung cancer (3 arms). Primary endpoints: Urinary 8-hydroxydeoxyguanosine Levels at 6 months and Urinary 8-F2-isoprostanes Levels at 6 months. Started May 2004; status: completed.
02
Drugs
green tea extract
03
Conditions
lung cancer
Beyond the preview
Go deeper on NCT00363805.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00363805.